
Taraasian Drugs Private Limited
Provides research and development services in medical science, operates hospitals, clinics, and diagnostic centers.
Provides research and development services in medical science, operates hospitals, clinics, and diagnostic centers.
Taraasian Drugs Private Limited (TDPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 July 2017 (Seven years and seven months 25 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Marliwar, Bhushan Marliwar, Bhraman Marliwar, and Eight other members serve as directors at the Company.
Nagpur, Maharashtra, India
+91-XXXXXXXXXX
U74999MH2017PTC297577
297577
Private Limited Indian Non-Government Company
19 Jul 2017
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bhupendra Marliwar ![]() | Director | 29-Sep-2017 | Current |
Bhushan Marliwar ![]() | Director | 19-Jul-2017 | Current |
Bhraman Marliwar ![]() | Director | 19-Jul-2017 | Current |
Archana Deshmukh ![]() | Director | 26-Feb-2019 | Current |
Vaishali Lande ![]() | Director | 26-Feb-2019 | Current |
Girish Marliwar ![]() | Director | 03-Aug-2019 | Current |
Taraasian Drugs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.85% decrease. The company also saw a substantial fall in profitability, with a 787.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.32%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Taraasian Drugs had a promoter holding of 87.85% and a public holding of 12.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Bhupendra Marliwar is a mutual person
Bhupendra Marliwar, Bhushan Marliwar and 1 more are mutual person
Bhupendra Marliwar and Bhushan Marliwar are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Taraasian Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Taraasian Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taraasian Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Taraasian Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Taraasian Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Nitin Uttam Meshram was appointed as a Additional Director was appointed as a Additional Director on 13 Jan 2020 & has been associated with this company since 5 years 2 months .
Girish Balwantrao Marliwar was appointed as a Director was appointed as a Director on 03 Aug 2019 & has been associated with this company since 5 years 7 months .
Vinayak Prabhakar Polke was appointed as a Director was appointed as a Director on 03 Aug 2019 & has been associated with this company since 5 years 7 months .
Archana Vijay Dharne was appointed as a Director was appointed as a Director on 03 Aug 2019 & has been associated with this company since 5 years 7 months .
Taraasian Drugs Private Limited was incorporated on 19 Jul 2017.
The authorized share capital of Taraasian Drugs Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 11 directors are associated with Taraasian Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Taraasian Drugs Private Limited is Plot No. 10 Ground Floor Dnyan Yog Appt. Deo Nagar, Khamla Road India, Nagpur, Maharashtra, 440015.
The corporate identification number (CIN) of Taraasian Drugs Private Limited is U74999MH2017PTC297577 and the company number is 297577 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Taraasian Drugs Private Limited has fallen by -10.85%.
The financial reports for the fiscal year 2022 indicates that The net worth of Taraasian Drugs Private Limited has experienced an downturn of -22.32%.
The most recent Balance Sheet for Taraasian Drugs Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
AD
SJ
SH